Generic Name and Formulations:
Diatrizoate meglumine 300mg/mL; soln for inj; contains organically bound iodine 141mg/mL.
Indications for CYSTOGRAFIN:
Take laxative night before exam; low residue diet day before. Individualize. Fill bladder with 25–300mL depending on age of patient and degree of bladder irritability; >300mL may be used if bladder capacity allows.
Severe sensitivity reactions may occur; have emergency equipment available. Bronchial asthma. Significant allergies. Active UTI. Pregnancy (Cat.C).
Radiopaque contrast agent.
May interfere with urine specimens.
Hypersensitivity reactions, hypothyroidism.
Bottles (100mL, 300mL)—1; Dilute (300mL)—10
Endocrinology Advisor Articles
- Long-Term Efficacy and Safety of Dapagliflozin for Type 1 Diabetes
- Measuring Time in Range During CGM May Be Useful Outcome Metric for Clinical Trials
- HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality
- Safety and Effectiveness of the Most Common Bariatric Procedures Examined
- AHA, ADA Announce Joint Education Initiative to Reduce CVD Deaths in T2D
- High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes
- Online Tool Helps Patients With Advance Care Planning
- Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes
- Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection
- Technological Breakthroughs in Medicine Move Physician-Patient Interactions From The Computer Screen Back to the Exam Room